1. Clinical evaluation of allogeneic mesenchymal stem cells for Alzheimer's disease: Human/Human trials: Inflammation. (7th December 2020) Authors: Oliva, Anthony A.; Baumel, Bernard; Brody, Mark; Agronin, Marc; Herskowitz, Brad; Bookheimer, Susan Y; McClain‐Moss, Lisa; Hitchinson, Ben; Ramdas, Kevin; Pena, Andrea; Diaz, Liliana A.; Green, Geoff; Perez, Carmen; Fuquay, Ana; Castaneda, Ricardo; Rodriguez, Savannah; Delucca, Johanna; Hare, Jos... Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detection of Amyloid β Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer's Disease. (December 2015) Authors: Kerbage, Charles; Sadowsky, Carl H.; Tariot, Pierre N.; Agronin, Marc; Alva, Gustavo; Turner, F. Darell; Nilan, Dennis; Cameron, Anne; Cagle, Gerald D.; Hartung, Paul D. Journal: American journal of Alzheimer's disease & other dementias Issue: Volume 30:Number 8(2015) Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of empathic communication behaviors for enhancement of person center care: A blueprint. (1st February 2022) Authors: Brown, Ellen L; Agronin, Marc; Garcai, Stephanie Jasmine; Moore, Stefanie Nicole Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 7 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of empathic communication behaviors for enhancement of person center care: A blueprint. (December 2021) Authors: Brown, Ellen L; Agronin, Marc; Garcai, Stephanie Jasmine; Moore, Stefanie Nicole Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 7 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O1–04–01: Testing the use of standardized scripts for disclosing 'hypothetical/mock' amyloid PET scan results to nondemented cognitively impaired patients and their care partners. (1st July 2013) Authors: Witte, Michael; Barnes, Janet; Lingler, Jennifer; Agronin, Marc; Hochstetler, Helen; Healey, Kristine; Hake, Ann; Trzepacz, Paula Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 3 Page Start: P131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O2‐05‐05: DETECTION OF LIGAND BOUND TO BETA AMYLOID IN THE LENSES OF HUMAN EYES. (1st July 2014) Authors: Kerbage, Charles; Hartung, Paul D.; Sadowsky, Carl; Tariot, Pierre; Agronin, Marc; Alva, Gustavo; Turner, Darell; Nilan, Dennis; Cameron, Anne; Cagle, Gerald Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 2 Page Start: P173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O4‐09‐05: Dextromethorphan/quinidine (AVP‐923) for treatment of agitation in patients with Alzheimer's disease: Analysis of week 10 results for patients treated only with AVP‐923 versus patients receiving only placebo (NCT01584440). (1st July 2015) Authors: Cummings, Jeffrey L.; Lyketsos, Constantine; Peskind, Elaine R.; Porsteinsson, Anton P.; Mintzer, Jacobo E.; Scharre, Douglas W.; De La Gándara, José E.; Agronin, Marc; Nguyen, Uyen; Shin, Paul; Tariot, Pierre N.; Siffert, Joao Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7S:Part 6 Page Start: P291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P2‐039: PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE. (1st July 2019) Authors: Oliva, Anthony A.; Baumel, Bernard; Brody, Mark; Agronin, Marc; Drouillard, Amy; Pena, Andrea; McClain-Moss, Lisa; Page, Suzanne L.; Perez, Carmen; Landman, Jonathan; Alston, Tequesta; Bookheimer, Susan Y.; Castaneda, Ricardo; Hare, Joshua M. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 11 Page Start: P586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P3‐021: Treatment With Memantine and a Cholinesterase Inhibitor Reduces Agitation in Patients With Moderate to Severe Alzheimer's Disease and Behavioral Disturbances. (1st July 2016) Authors: Agronin, Marc; Hendrix, Suzanne; Ellison, Noel; Dass, Biplob; Edwards, John Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 17 Page Start: P825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P3‐301: Dextromethorphan/quinidine (AVP‐923) phase 2 study for treatment of agitation in Alzheimer's disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440). (1st July 2015) Authors: Cummings, Jeffrey L.; Lyketsos, Constantine; Peskind, Elaine R.; Porsteinsson, Anton P.; Mintzer, Jacobo E.; Scharre, Douglas W.; De La Gándara, José E.; Agronin, Marc; Davis, Charles S.; Nguyen, Uyen; Shin, Paul; Tariot, Pierre N.; Siffert, Joao Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 16 Page Start: P751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗